Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells

Drug Metabolism and Disposition

Volumn 38, Issue 12, 2010, Pages 2105-2109

  Hu, Dong Gui ^a   Mackenzie, Peter I ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 2B15; GLUCURONOSYLTRANSFERASE 2B17; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN FUNCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONOSYLTRANSFERASE; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MALE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 78649559171     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.035436     Document Type: Article

References (24)

1. Bao BY, Chuang BF, Wang Q, Sartor O, Balk SP, Brown M, Kantoff PW, and Lee GS (2008) Androgen receptor mediates the expression of UDP- glucuronosyltransferase 2 B15 and B17 genes. Prostate 68:839-848. (Pubitemid 351845215)
2. Barbier O and Bélanger A (2008) Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate. Best Pract Res Clin Endocrinol Metab 22:259-270.
3. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297.
4. Chouinard S, Barbier O, and Bélanger A (2007) UDP- glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J Biol Chem 282:33466-33474.
5. Chouinard S, Pelletier G, Bélanger A, and Barbier O (2004) Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. Endocr Res 30:717-725.
6. Chouinard S, Pelletier G, Bélanger A, and Barbier O (2006) Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Endocrinology 147:5431-5442.
7. Chouinard S, Yueh MF, Tukey RH, Giton F, Fiet J, Pelletier G, Barbier O, and Bélanger A (2008) Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. J Steroid Biochem Mol Biol 109:247-253.
8. Congiu M, Mashford ML, Slavin JL, and Desmond PV (2002) UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab Dispos 30:129-134.
9. Dubois SG, Beaulieu M, Lévesque E, Hum DW, and Bélanger A (1999) Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution. J Mol Biol 289:29-39. (Pubitemid 29278361)
10. Hu DG, Gardner-Stephen DA, Severi G, Gregory PA, Treloar J, Giles GG, English D, Hopper J, Tilley WD, and Mackenzie PI (2010) A novel polymorphism in a FOXA1 binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3{alpha}, 17{beta}-diol glucuronide. Mol Pharmacol 78:714-722.
11. Hu DG and Mackenzie PI (2009) Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells. Mol Pharmacol 76:425-439.
12. Kaarbø M, Klokk TI, and Saatcioglu F (2007) Androgen signaling and its interactions with other signaling pathways in prostate cancer. Bioessays 29:1227-1238.
13. Kaeding J, Bélanger J, Caron P, Verreault M, Bélanger A, and Barbier O (2008a) Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells. Mol Cancer Ther 7:380-390. (Pubitemid 351302531)
14. Kaeding J, Bouchaert E, Bélanger J, Caron P, Chouinard S, Verreault M, Larouche O, Pelletier G, Staels B, Bélanger A, et al. (2008b) Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells. Biochem J 410:245-253.
15. Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, and Labrie C (2005) Is dehydroepiandrosterone a hormone? J Endocrinol 187:169-196.
16. Lai E, Prezioso VR, Smith E, Litvin O, Costa RH, and Darnell JE Jr (1990) HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev 4:1427-1436.
17. Lai E, Prezioso VR, Tao WF, Chen WS, and Darnell JE Jr (1991) Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 5:416-427.
18. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, and Brown M (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132:958-970.
19. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC, Dallaire S, Gabriel SB, Lee C, Daly MJ, et al. (2006) Common deletion polymorphisms in the human genome. Nat Genet 38:86-92.
20. Mincheva A, Lichter P, Schütz G, and Kaestner KH (1997) Assignment of the human genes for hepatocyte nuclear factor 3-alpha, -beta, and -gamma (HNF3A, HNF3B, HNF3G) to 14q12-q13, 20p11, and 19q13.2-q13.4. Genomics 39:417-419.
21. Mirosevich J, Gao N, Gupta A, Shappell SB, Jove R, and Matusik RJ (2006) Expression and role of Foxa proteins in prostate cancer. Prostate 66:1013-1028.
22. Myatt SS and Lam EW (2007) The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7:847-859.
23. Turgeon D, Carrier JS, Lévesque E, Beatty BG, Bélanger A, and Hum DW (2000) Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489-504.
24. Turgeon D, Carrier JS, Lévesque E, Hum DW, and Bélanger A (2001) Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787. (Pubitemid 32222427)